# Intraperitoneal Bupivacaine With Magnesium or Nalbuphine for Postoperative Pain Control in Laparoscopic Hysterectomy

> **NCT03393572** · PHASE4 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 80 (actual)

## Conditions studied

- Anesthesia

## Interventions

- **DRUG:** Bupivacaine 0.25%
- **DRUG:** Magnesium sulphate.
- **DRUG:** nalbuphine

## Key facts

- **NCT ID:** NCT03393572
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-03
- **Primary completion:** 2018-06-05
- **Final completion:** 2018-06-15
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2019-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03393572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03393572, "Intraperitoneal Bupivacaine With Magnesium or Nalbuphine for Postoperative Pain Control in Laparoscopic Hysterectomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03393572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*